Tenet Healthcare Corp (THC) FinancialsTHCTenet Healthcare Corp

Tenet Healthcare Corp (THC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Hospital operations and other, accounting for 75.4% of total sales, equivalent to $4.05B. Another important revenue stream is Ambulatory Care. Understanding this composition is critical for investors evaluating how THC navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Tenet Healthcare Corp maintains a gross margin of 78.70%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 20.06%, while the net margin is 18.57%. These profitability ratios, combined with a Return on Equity (ROE) of 53.31%, provide a clear picture of how effectively THC converts its operational activities into shareholder value.

In the context of the broader market, THC competes directly with industry leaders such as UHS and CHE. With a market capitalization of $21.48B, it holds a leading position in the sector. When comparing efficiency, THC's gross margin of 78.70% stands against UHS's 100.00% and CHE's 30.37%. Such benchmarking helps identify whether Tenet Healthcare Corp is trading at a premium or discount relative to its financial performance.

Tenet Healthcare has demonstrated solid financial performance, with a gross margin of 78.70% in the latest quarter and a net income of $826 million in Q2 2026, reflecting strong profitability.